Synflorix
Analogs of Synflorix
Find cheaper analogs and generic equivalents for Synflorix.
ਸਰਗਰਮ ਤੱਤ: Pneumococcal polysaccharide serotype 23F;Pneumococcal polysaccharide serotype 4;Pneumococcal polysaccharide serotype 5;Pneumococcal polysaccharide serotype 6B;Pneumococcal polysaccharide serotype 7F;Pneumococcal polysaccharide serotype 9V;Pneumococcal polysaccharide serotype 1;Pneumococcal polysaccharide serotype 14;Pneumococcal polysaccharide serotype 18C;Pneumococcal polysaccharide serotype 19F
ਉਤਪਾਦ ਝਲਕ
About Synflorix
Synflorix is a vaccine that contains parts of the bacterium Streptococcus pneumoniae (S. pneumoniae, also called pneumococcus).
What it is used for
Synflorix is used to protect infants and children aged between 6 weeks and 5 years against invasive disease, pneumonia (infection of the lungs) and acute otitis media (infection of the middle ear) caused by S. pneumoniae.
How it is used
Synflorix is available as a suspension for injection. It can only be obtained with a prescription. The vaccination schedule for Synflorix depends on the age of the child and should be based on official recommendations.
Infants aged between 6 weeks and 6 months are given a course of three doses with an interval of at least one month between each dose, with the first dose usually given at 2 months of age. A fourth (‘booster’) dose is recommended at least 6 months after the third dose, preferably when the child is between 12 and 15 months of age.
When Synflorix is given as part of a routine infant immunisation programme, a course of two doses may be given 2 months apart, from the age of 6 weeks, followed by a booster dose at least 6 months later.
Children aged under 6 months with conditions that make them more likely to catch these invasive diseases, such as those with human immunodeficiency virus (HIV) infection, sickle cell disease or spleen problems, should be given three doses followed by a booster dose.
Premature babies (born between 27 and 36 weeks gestation) are given a course of three doses with an interval of at least one month between each dose, with the first dose given at 2 months of age. It is recommended that a booster dose be given at least 6 months after the third dose.
Infants aged between 7 and 11 months are given a course of two doses with an interval of at least one month between them. It is recommended that a booster dose is given at least 2 months after the second dose, during the child’s second year of life.
Children aged between 12 months and 5 years are given a course of two doses with an interval of at least 2 months between them. The vaccine is given by injection into the thigh muscle in infants or into the shoulder muscle in young children.
How it works
Synflorix is a vaccine that protects against infections caused by S. pneumoniae. Vaccines work by ‘teaching’ the immune system (the body’s natural defences) to defend the body against the infection.
When a person is given the vaccine, the immune system recognises the parts of the bacterium in the vaccine as ‘foreign’ and makes antibodies against them. The immune system will then be able to produce antibodies more quickly when it comes into contact with the bacterium again.
This helps to protect against the disease. Synflorix contains small amounts of polysaccharides (a type of sugar) extracted from the ‘capsule’ that surrounds the S. pneumoniae bacterium.
These polysaccharides have been purified, then conjugated (attached) to a carrier to help them to be recognised by the immune system. The vaccine is also adsorbed (fixed) onto an aluminium compound to stimulate a better response.
Synflorix contains the polysaccharides from ten different types of S. pneumoniae (serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F and 23F).
Active substance: Not specified.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.